Search results
Showing 7471 to 7485 of 8223 results
DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)
This advice has been updated and replaced by NICE healthtech guidance 594.
AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)
This advice has been updated and replaced by NICE healthtech guidance 607.
This advice has been updated and replaced by NICE Healthtech guidance 615.
KardiaMobile for the ambulatory detection of atrial fibrillation (MIB232)
This advice has been updated and replaced by NICE healthtech guidance 606.
This advice has been updated and replaced by NICE healthtech guidance 602.
Leukomed Sorbact for preventing surgical site infection (MIB197)
This advice has been updated and replaced by NICE healthtech guidance 567.
Plus Sutures for preventing surgical site infection (MIB204)
This advice has been updated and replaced by NICE healthtech guidance guidance 586.
This advice has been updated and replaced by NICE healthtech guidance 601.
This advice has been updated and replaced by NICE healthtech guidance 624.
This advice has been updated and replaced by NICE healthtech guidance 574.
This advice has been updated and replaced by NICE healthtech guidance 616.
We have moved Medical technologies guidance 77 to become HealthTech guidance 715. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Medical technologies guidance 76 to become HealthTech guidance 671. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)
We have moved medical technologies guidance 8 to become HealthTech guidance 275. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
GreenLight XPS for treating benign prostatic hyperplasia (MTG74)
We have moved Medical technologies guidance 74 to become HealthTech guidance 650. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.